What is Roth Capital’s Estimate for CVE:HIV FY2025 Earnings?

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Research analysts at Roth Capital lifted their FY2025 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.54) for the year, up from their previous forecast of ($0.55). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.04) EPS, FY2027 earnings at $0.23 EPS and FY2028 earnings at ($0.10) EPS.

Several other equities analysts also recently commented on the stock. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th. Finally, Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Four analysts have rated the stock with a strong buy rating, Based on data from MarketBeat, the company presently has an average rating of “Strong Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.